CG
OLMA icon

Cutler Group’s Olema Pharmaceuticals OLMA Stock Holding History

Cutler Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,200
Closed -$3K – 4961
2022
Q3 		$3K Sell
1,200
-200
-14% -$848 ﹤0.01% 4002
2022
Q2 		$5K Hold
1,400
– – ﹤0.01% 3732
2022
Q1 		$5K Sell
1,400
-5,500
-80% -$30.3K ﹤0.01% 4145
2021
Q4 		$64K Buy
+6,900
New +$143K ﹤0.01% 2207

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Cutler Group's OLMA Position: Q4 2022 in Review

Cutler Group sold out of Olema Pharmaceuticals (OLMA) in Q4 2022, closing a stake of 1,200 shares — an estimated $3K sold.

Cutler Group first reported a position in OLMA in Q4 2021 and held it in 4 quarters. The position peaked at $64K in Q4 2021. 67 funds tracked by Wall St. Rank hold OLMA as of Q4 2022.

  • Cutler Group reported no remaining Olema Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 1,200 Olema Pharmaceuticals shares in Q4 2022, an estimated $3K.
  • Cutler Group first reported a position in Olema Pharmaceuticals in Q4 2021 and held it in 4 quarters.
  • Cutler Group's Olema Pharmaceuticals position peaked at $64K in Q4 2021.
  • 67 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.